Abstract:The primary role of the innate immune response is to limit the spread of infectious pathogens, with activation of Toll-like receptor (TLR) and RIG-like receptor (RLR) pathways resulting in a pro-inflammatory response required to combat infection. Limiting the activation of these signaling pathways is likewise essential to prevent tissue injury in the host. Triad3A is an E3 ubiquitin ligase that interacts with several components of TLR signaling and modulates TLR activity. In the present study, we demonstrate that Triad3A negatively regulates the RIG-I RNA sensing pathway through Lys48-linked, ubiquitin-mediated degradation of the tumor necrosis factor receptor-associated factor 3 (TRAF3) adapter. Triad3A was induced following dsRNA exposure or virus infection and decreased TRAF3 levels in a dose-dependent manner; moreover, Triad3A expression blocked IRF-3 activation by Ser-396 phosphorylation and inhibited the expression of type 1 interferon and antiviral genes. Lys48-linked ubiquitination of TRAF3 by Triad3A increased TRAF3 turnover, whereas reduction of Triad3A expression by stable shRNA expression correlated with an increase in TRAF3 protein expression and enhancement of the antiviral response following VSV or Sendai virus infection. Triad3A and TRAF3 physically interacted together, and TRAF3 residues Y440 and Q442--previously shown to be important for association with the MAVS adapter--were also critical for Triad3A. Point mutation of the TRAF-Interacting-Motif (TIM) of Triad3A abrogated its ability to interact with TRAF3 and modulate RIG-I signaling. TRAF3 appears to undergo sequential ubiquitin "immuno-editing" following virus infection that is crucial for regulation of RIG-I-dependent signaling to the antiviral response. Thus, Triad3A represents a versatile E3 ubiquitin ligase that negatively regulates RIG-like receptor signaling by targeting TRAF3 for degradation following RNA virus infection.

E3 ubiquitin ligase SIAH1 mediates ubiquitination and degradation of TRB3

BRI3 Associates with SCG10 and Attenuates NGF-induced Neurite Outgrowth in PC12 Cells

TRB3 interacts with CtIP and is overexpressed in certain cancers.

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

TRB3 interacts with SMAD3 promoting tumor cell migration and invasion

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

TRIB3 Inhibits Proliferation and Promotes Osteogenesis in Hbmscs by Regulating the ERK1/2 Signaling Pathway.

Ubiquitin E3 Ligase SCF(β-TRCP) Regulates TRIB2 Stability in Liver Cancer Cells.

Axin and GSK3- Control Smad3 Protein Stability and Modulate TGF- Signaling.

SCFβ-TRCP E3 Ubiquitin Ligase Targets the Tumor Suppressor ZNRF3 for Ubiquitination and Degradation

E3 ubiquitin ligase TRIM31: A potential therapeutic target

The Ubiquitin Ligase Traf6 Negatively Regulates The Jak-Stat Signaling Pathway By Binding To Stat3 And Mediating Its Ubiquitination

E3 Ubiquitin Ligases: Key Regulators of TGF Signaling in Cancer Progression

TRB3 Links the E3 Ubiquitin Ligase COP1 to Lipid Metabolism.

E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression

The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation

The p90 ribosomal S6 kinase-UBR5 pathway controls Toll-like receptor signaling via miRNA-induced translational inhibition of tumor necrosis factor receptor-associated factor 3

The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition

The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara

The E3 Ligase TRAF4 Promotes IGF Signaling by Mediating Atypical Ubiquitination of IRS-1

Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination